Back
Abbott Laboratories 10K Form
Buy
65
ABT
Abbott Laboratories
Last Price:
$127.42
Seasonality Move:
4.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | ABT/Abbott Laboratories Quarterly |
2024-02-16 | 10K | ABT/Abbott Laboratories Annual |
2023-11-01 | 10Q | ABT/Abbott Laboratories Quarterly |
2023-08-03 | 10Q | ABT/Abbott Laboratories Quarterly |
2023-05-04 | 10Q | ABT/Abbott Laboratories Quarterly |
2023-02-17 | 10K | ABT/Abbott Laboratories Annual |
Receive ABT News And Ratings
See the #1 stock for the next 7 days that we like better than ABT
ABT Financial Statistics
Sales & Book Value
Annual Sales: | $42B |
---|---|
Cash Flow: | $2.1B |
Price / Cash Flow: | 35.07 |
Annual Sales: | $27.52 |
Price / Book: | 4.64 |
Profitability
EPS (TTM): | 7.65000 |
---|---|
Net Income (TTM): | $13.4B |
Gross Margin: | $23.2B |
Return on Equity: | 32.63% |
Return on Assets: | 17.9% |
Abbott Laboratories Earnings Forecast
Key Abbott Laboratories Financial Ratios
-
The Gross Profit Margin over the past 41 years for ABT is 55.41%.
-
The Selling, General & Administrative Expenses for ABT have been equal to 27.88% of Gross Profit Margin.
-
The Research & Development expenses have been 6.78% of Revenue.
-
The Interest Expense is 4.17% of Operating Income.
-
The Net Earning history of ABT is 31.95% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 30 years.
Abbott Laboratories Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | ABT |
CUSIP: | 002824 |
Website: | abbottinvestor.com |
Debt
Debt-to-Equity Ratio: | 0.3 |
---|---|
Current Ratio: | 1.67 |
Quick Ratio: | 1.23 |
Price-to-Earnings
Trailing P/E Ratio: | 16.68 |
---|---|
Forward P/E Ratio: | 22.36 |
ABT Technical Analysis vs Fundamental Analysis
Buy
65
Abbott Laboratories (ABT)
is a Buy
Is Abbott Laboratories a Buy or a Sell?
-
Abbott Laboratories stock is rated a BuyThe current Abbott Laboratories [ABT] share price is $127.42. The Score for ABT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.